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OBJECTIVES: Familial steroid-sensitive idiopathic nephrotic syndrome is rare, and only approximately 3% of
patients have affected siblings.
METHODS: Herein, we report seven cases of patients with steroid-sensitive idiopathic nephrotic syndrome from
three Chinese families. Mutational screening of the Nphs2 gene was performed in all the patients.
RESULTS: All seven of the familial steroid-sensitive idiopathic nephrotic syndrome cases in our sample exhibited
minimal change disease, and one case also presented with mesangial proliferative glomerulonephritis,
according to the renal pathology. No significant was associations were found between Nphs2 gene mutations
and the onset of proteinuria and nephrotic syndrome in these familial cases.
CONCLUSIONS: The presence of minimal change disease is important, but it is not an unusual finding in patients
with familial steroid-sensitive idiopathic nephrotic syndrome, which appears to be clinically benign and
genetically distinct from other types of nephrosis.
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Nephrotic syndrome is defined by the presence of
proteinuria, hypoalbuminemia, edema, and hyperlipidemia.
This syndrome is one of the most common diagnoses in
pediatric nephrology, and it is emerging as a leading cause
of uremia. The most common variant of nephrotic syndrome
in children is idiopathic nephrotic syndrome (INS).
Podocin, which is encoded by the Nphs2 gene, is an
important molecule expressed in glomerular podocytes and
the slit diaphragm. Since the identification of Nphs2 (1),
several groups have demonstrated that mutations in the
Nphs2 gene represent a frequent cause of steroid-resistant
nephrotic syndrome (SRNS) and are found in 20–30% of
sporadic cases of SRNS (2).
Most children with sporadic INS respond to steroid
treatment, in which case the disease has a favorable
outcome and does not progress to end-stage renal disease.
Few reports of familial cases of steroid-sensitive idiopathic
nephrotic syndrome (SSINS) have been published (3–7).




The first case was an 8-year-old girl who presented on
March 3, 2004 with edema, massive proteinuria, and
hypoalbuminemia that had persisted for seven days. The
level of protein in a 24-hr urine sample was 3.42 g, and the
blood albumin concentration was 14.5 g/L. Primary
nephrotic syndrome was diagnosed, and treatment with
1.5 mg/kg/day of prednisone was initiated. Over time, the
patient developed frequently relapsing nephrotic syndrome,
and a renal biopsy performed in 2006 revealed minimal
change disease (MCD). Subsequently, pulse cyclophospha-
mide (CTX) therapy was applied for four months at a total
dose of 145 mg/kg CTX. The patient achieved remission
and has since maintained this state.
The second case was a 5-year-old boy (the brother of the
first patient) who was admitted for edema and proteinuria
on April 10, 2008. The level of protein in a 24-hr urine
sample was 2.65 g, and the blood albumin concentration
was 15.1 g/L. This patient was treated with 2 mg/kg/day
prednisolone, and he achieved remission after 12 days. He
had five episodes of relapse during the following six
months, and a renal biopsy revealed MCD. The patient
received 25 mg/kg/day mycophenolate mofetil (MMF) and
has since remained in remission.
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Direct DNA sequencing was performed after polymerase
chain reaction (PCR) amplification of the 29 exons of the
Nphs1 gene and the 8 exons of the Nphs2 gene in both
patients. No homozygous or compound heterozygous
mutations in either gene were found in either patient,
except for 1 known single-nucleotide polymorphism (SNP;
V763V) in Nphs1 in the second case. These patients were not
born to consanguineous parents.
Family 2 (8)
The third case was a 13-year-old boy with steroid-
sensitive nephrotic syndrome. The patient underwent a
biopsy, which revealed MCD. He achieved remission after
prednisone therapy and has had no relapses in the 9.5 years
since the biopsy.
The fourth case was a 15-year-old boy (the brother of the
third patient) who had four relapses at 17, 18, 20, and 22
years of age. After the fourth relapse, the patient underwent
a renal biopsy, which identified MCD. After two weeks of
prednisone therapy, the proteinuria disappeared, and the
patient has maintained normal renal function for the past
3.6 years.
The fifth patient was a 35-year-old man (the brother of the
third and fourth patients) who developed nephrotic
syndrome. Despite a 2-year history of hypertension, he
had not undergone urine testing. Immunofluorescence
analysis of a renal biopsy revealed IgG and IgA deposits, and
an electron microscopic analysis revealed segmental foot
process effacement and mild electron-dense deposits in the
mesangial area (Figure 2). The pathology diagnose was
mesangial proliferative glomerulonephritis (MsPGN). The
patient received prednisone treatment and achieved remission.
Denaturing high-performance liquid chromatography
(DHPLC) was performed following the PCR amplification of
all eight exons of the Nphs2 gene in patients 3, 4, and 5
(described above). No homozygous or compoundheterozygous
mutations in the Nphs2 gene were found in any of these three
patients. There was no parental consanguinity in this family.
Patient X (P-X) and patient Y (P-Y) (Figure 1) also
exhibited moderate proteinuria (a result of ++) based on a
urine dipstick test, but no further investigations were
performed. No quantitative evaluation of the proteinuria
was undertaken in either patient.
Family 3
The sixth case was a 2.8-year-old boy who was admitted
with palpebral edema. A quantitative analysis revealed that
his 24-hr urine protein level was 1.82 g. The serum albumin
concentration was 12.7 g/L, the serum cholesterol was
12.89 mmol/L, and the serum creatinine level was
26.7 mmol/L. The patient received 2 mg/kg/day predni-
sone and achieved remission 6 days after treatment. One
Figure 1 - The pedigrees of families 1–3, which include individuals with steroid-sensitive idiopathic nephrotic syndrome.
Figure 2 - Slight mesangial proliferation and matrix expansion in glomeruli from patient 5.
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month later, he experienced a single episode of relapse
involving an upper respiratory infection and exhibited
proteinuria, which resolved within 10 days. This patient
has remained in remission for 3 years.
The seventh case was a 3-year-old boy who was the
dizygotic twin of patient 6. The onset of his proteinuria and
edema occurred 2 months later than that of patient 6. The
24-hr urine protein level was 2.16 g, the serum albumin
concentration was 12.4 g/L, and the cholesterol level was
11.77 mmol/L. The patient was treated with prednisone at a
dose of 1.8 mg/kg/day, and remission was observed 15
days after the steroid therapy was initiated. His urinary test
results have remained normal for the past 2.8 years.
Patients 6 and 7 were born to nonconsanguineous parents.
Neither boy underwent a renal biopsy. The mutational
screening of the Nphs2 gene using PCR and direct sequencing
revealed no significant mutations in either dizygotic twin.
Secondary causes of nephrotic syndrome, including sys-
temic lupus erythematosus, malignancy, hepatitis B infection,
and Henoch-Schonlein purpura, were excluded in all the
patients. Hematuria, hypertension, and hypocomplementemia
were absent in all the cases. The clinical parameters and
treatment responses to prednisone/immunosuppressants of
patients 1–7 are summarized in Table 1. This study was
approved by the ethics committee of The Children’s Hospital
of Zhejiang University School of Medicine.
& DISCUSSION
Familial SSINS is a rare condition, and only approxi-
mately 3% of patients have affected siblings (9).
Nonetheless, the occasional occurrence of familial SSINS
points to a genetic predisposition for this syndrome (2,10).
No genes involved in familial SSINS have yet been
identified. Kari et al. (5) investigated the major histocom-
patibility complex class I and II loci in three Bengali families
with nine children affected by steroid-sensitive nephrotic
syndrome. However, no correlations between a predisposi-
tion for this disease and the human leukocyte antigen
(HLA)-encoding genes were found. Fuchshuber (4) reported
a cohort of 32 cases of SSINS from 15 families who
experienced disease onset during childhood. The results of
linkage studies and mutational analyses indicated that
familial SSINS was not associated with the Nphs2 gene.
This gene has been linked to focal segmental glomerulo-
sclerosis (FSGS) in certain cases of autosomal recessive
SRNS based on the pathology and rapid progression to end
stage renal disease (ESRD). In the present study, a
mutational analysis of the Nphs2 gene (11) was conducted
for all seven patients from three families, and no homo-
zygous or compound heterozygous mutations were found.
One known polymorphism (V736V) in the Nphs1 gene,
which does not involve an amino acid substitution, was
found in patient 2. We have also reported finding this
polymorphism in Chinese children with sporadic steroid-
resistant nephrotic syndrome (11). For that reason, we
assumed that V736V was not a pathogenic mutation in this
patient with familial SSINS.
Motoyama et al. (3) summarized the histological findings
from 41 familial SSINS patients, all of whom were found to
have MCD. In the present study, two cases from Family 1
and 2 cases from Family 2 presented with MCD, whereas
one case from Family 2 presented with MsPGN. To our
knowledge, this is the first reported case of familial SSINS
with MsPGN pathology, and it is unclear whether there was
an association between the age at onset (35 years vs. 2.5–15
years) and the pathology (MsPGN vs. MCD) in these cases.
For patient 5 (who presented with MsPGN), we excluded
minimal change nephrotic syndrome with mesangial
hypercellularity (no IgA deposits were observed using
immunofluorescence and electron microscopy) and IgA
nephropathy associated with minimal change nephrotic
syndrome (the immunofluorescence analysis revealed pre-
dominantly IgA deposits in the mesangial area). Renal
biopsies are not typically conducted in familial SSINS
patients because the course of the disease is favorable in
children. In a study reported by Fuchshuber (4), only 12 of
32 familial SSINS patients underwent renal biopsies. It is
possible that MCD is not a unique pathological finding in
patients with familial SSINS; further research is needed.
Environmental factors (e.g., preceding infection, infec-
tious agents, or medications) may trigger the onset of
nephrotic syndrome in several members of the same family
over a short period of time. In Family 3, the onset of
proteinuria and edema was separated by only two months
in patients 6 and 7. Environmental factors may have played
a role in the pathogenesis of proteinuria in this family (12).
However, prior to the onset of proteinuria, neither patient
had any history of viral, mycoplasma, or bacterial infections;
allergies to milk or dust; asthma; neoplasms; or the use of
medications associated with proteinuria, such as NSAIDs or
antimicrobials. Therefore, we favor the hypothesis that there
is a genetic predisposition to SSINS in this family.
In conclusion, familial SSINS is rare, but it is occasion-
ally encountered in the clinic. No genes related to this
Table 1 - Seven cases of steroid-sensitive nephrotic syndrome from three families.
Family 1 2(8) 3
Case 1 2 3 4 5 6 7
Sex (M/F) F M M M M M M
Age at onset (years) 8 5 13 15 35 2.8 2.9
Interval of onset (months) ? 49 ? 36 96 ? 2
Hematuria No No No No No No No
Hypertension No No No No Yes No No
Renal function Normal Normal Normal Normal Normal Normal Normal
Immunosuppressant Pre+CTX Pre+MMF Pre Pre Pre Pre Pre
Days to remission 13 12 Unknown 7 Unknown 10 15
Renal pathology MCD MCD MCD MCD MsPGN No No
Number of relapses 3 5 0 4 0 1 0
*Pre: prednisone, CTX: cyclophosphamide, MMF: mycophenolate mofetil, MCD: minimal change disease, MsPGN: mesangial proliferative
glomerulonephritis, F: female, M: male.
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condition have yet been identified, and further research is
necessary.
& ACKNOWLEDGMENTS
This project was supported by the National Natural Science Foundation of
China (Grant Nos. 81270792, 81070561, and 81170664), the Research
Fund for the Doctoral Program of Higher Education of China
(20120101110018), the Zhejiang Provincial Healthy Science Foundation
of China (WKJ2010-2-014, 2012KYA119), the Zhejiang Provincial
Program for the Cultivation of High-Level Innovative Health Talents,
and the Zhejiang Provincial Natural Science Foundation of China
(LY12H050037). We thank all the patients for participating in this study.
& AUTHOR CONTRIBUTIONS
Xia Y and Mao J were responsible for the data collection and manuscript
preparation. Xia J and Wang W were responsible for performing the renal
biopsies and mutational screening. Du L and Liu A were responsible for
the clinical management and follow-up of the patients.
& REFERENCES
1. RufRG, LichtenbergerA,Karle SM,Haas JP,Anacleto FE, SchultheissM, et al.
Patients with mutations in NPHS2 (podocin) do not respond to standard
steroid treatment of nephrotic syndrome. J Am Soc Nephrol. 2004;15(3):722-
32, http://dx.doi.org/10.1097/01.ASN.0000113552.59155.72.
2. Chang JW, Lin CY. Long-term outcome of heavy proteinuria in patients
under 2 years of age. Pediatr Nephrol. 2003;18(10):1044-8, http://dx.doi.
org/10.1007/s00467-003-1238-6.
3. Motoyama O, Sugawara H, Hatano M, Fujisawa T, Iitaka K. Steroid-
sensitive nephrotic syndrome in two families. Clin Exp Nephrol.
2009;13(2):170-3, http://dx.doi.org/10.1007/s10157-008-0117-7.
4. Fuchshuber A, Gribouval O, Ronner V, Kroiss S, Karle S, Brandis M, et al.
Clinical and genetic evaluation of familial steroid-responsive nephrotic
syndrome in childhood. J Am Soc Nephrol. 2001;12(2):374-8.
5. Kari JA, Sinnott P, Khan H, Trompeter RS, Snodgrass GJ. Familial
steroid-responsive nephrotic syndrome and HLA antigens in Bengali
children. Pediatr Nephrol. 2001;16(4):346-9, http://dx.doi.org/10.1007/
s004670000549.
6. Bensman A, Vasmant D, Mougenot B, Baudon JJ, Muller JY. Steroid-
responsive nephrotic syndrome in infants: 2 familial case reports. Arch
Fr Pediatr. 1982;39(6):381-3.
7. Ruf RG, Fuchshuber A, Karle SM, Lemainque A, Huck K, Wienker T,
et al. Identification of the first gene locus (SSNS1) for steroid-sensitive
nephrotic syndrome on chromosome 2p. J Am Soc Nephrol. 2003;
14(7):1897-00, http://dx.doi.org/10.1097/01.ASN.0000070070.03811.02.
8. Chen YQ, Zhang H, Lv JC, Zhou Y, Wang HY. A familial steroid-
responsive nephrotic syndrome report. Chin J Nephrol. 2003;19:378-80.
9. Moncrieff MW, White RH, Glasgow EF, Winterborn MH, Cameron JS,
Ogg CS. The familial nephrotic syndrome. II. A clinicopathological
study. Clin Nephrol. 1973;1(4):220-9.
10. Wang DY, Mao JH, Zhang Y, Gu WZ, Zhao SA, Chen YF, et al. Kimura
disease: a case report and review of the Chinese literature. Nephron Clin
Pract. 2009;111(1):c55-61, http://dx.doi.org/10.1159/000178980.
11. Mao J, Zhang Y, Du L, Dai Y, Gu W, Liu A, et al. NPHS1 and NPHS2
gene mutations in Chinese children with sporadic nephrotic syndrome.
Pediatr Res. 2007;61(1):117-22, http://dx.doi.org/10.1203/01.pdr.
0000250041.19306.3d.
12. Bockenhauer D, Debiec H, Sebire N, Barratt M, Warwicker P, Ronco P,
et al. Familial Membranous Nephropathy: An X-Linked Genetic
Susceptibility? Nephron Clin Pract. 2008;108(1):c10-c15, http://dx.doi.
org/10.1159/000112466.
CLINICS 2013;68(5):628-631 Seven cases of SSINS from three families
Xia Y et al.
631
